跳至主要内容
临床试验/NCT06973889
NCT06973889已完成2 期

Evaluation of IgY Antibodies Effectiveness in Egg Yolk Against Helicobacter Pylori in Removing Bacteria and Improving Clinical Symptoms in the Patients

Mashhad University of Medical Sciences2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年12月4日最近更新:
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
2
主要终点
Respiratory urea level (UBT) higher than cut off 50

研究概览

简要总结

  1. Investigating its effectiveness in removing bacteria in invivo conditions
  2. Investigating the effectiveness in improving the clinical symptoms of patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 78 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with gastritis or stomach ulcers whose Helicobacter infection has been confirmed by a doctor and age group 18 to 78 years, all genders, if accepted

排除标准

  • Acute perforation of esophagus, stomach and duodenum Hyperlipidemic people Those who are allergic to egg proteins Patients with stomach cancer

研究组 & 干预措施

Intervention

Experimental

12 grams of egg yolk powder containing about 2 grams of antibody twice a day for 2 weeks along with usual antibiotic treatment including OAC or omeprazole (40 mg/day), clarithromycin (1000 mg/day) and amoxicillin (2000 mg/day).

干预措施: Helicobacter pylori eradication therapy (Biological)

结局指标

主要结局

Respiratory urea level (UBT) higher than cut off 50

时间窗: Determination of respiratory urea (UBT) at the beginning of the study and 8 weeks after the start of the intervention

This test is performed with the help of a diagnostic kit. After oral ingestion of a capsule containing labeled carbon and the patient's exhalation into the kit, the amount of urea breathed in is determined by the device. A UBT value greater than 50 means Helicobacter pylori infection.

次要结局

  • Examining the patient's clinical symptoms including: abdominal pain, nausea, vomiting and bloating.(During the treatment period for 4 weeks from the beginning of the intervention.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

zahra esmaeili

Student

Mashhad University of Medical Sciences

研究点 (2)

Loading locations...

相似试验